Back
FibroGen Quote, Financials, Valuation and Earnings
Sponsored
FGEN
Sponsored
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.
Sell
46
FGEN
FibroGen
Last Price:
0.37
Seasonality Move:
88.99%
7 Day Trial
ALL ACCESS PASS
$
7
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More HereFibroGen Price Quote
$0.37
+0.02 (+5.71%)
(Updated: November 21, 2024 at 10:40 AM ET)
FibroGen Key Stats
Sell
46
FibroGen (FGEN)
is a Sell
Day range:
$0.34 - $0.36
52-week range:
$0.18 - $2.93
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.19
P/B ratio:
0%
Volume:
1.3M
Avg. volume:
1.5M
1-year change:
-33.85%
Market cap:
$34M
Revenue:
$147.8M
EPS:
$-1.23
How Much Does FibroGen Make?
Is FibroGen Growing As A Company?
FibroGen Stock Price Performance
What Is FibroGen 52-Week High & Low?
FibroGen Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy FibroGen?
Is FibroGen Cash Flow Positive?
FibroGen Return On Invested Capital
Data Unavailable
FibroGen Earnings Date & Stock Price
-
What Is FibroGen's Stock Price Today?
A single share of FGEN can be purchased today for 0.35 -
What Is FibroGen’s Stock Symbol?
FibroGen trades on the nasdaq under the ticker symbol: FGEN -
When Is FibroGen’s Next Earnings Date?
The next quarterly earnings date for FibroGen is scheduled on February 26, 2025 -
When Is FGEN's next ex-dividend date?
FibroGen's next ex-dividend date is November 21, 2024 -
How To Buy FibroGen Stock?
You can buy FibroGen shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
FibroGen Competitors
FibroGen Dividend Yield
-
What Is FGEN Dividend Yield?
FibroGen’s dividend yield currently is 0% -
What Is FibroGen’s Payout Ratio?
FibroGen’s payout ratio is 0% -
When Did FibroGen Last Pay A Dividend?
The latest dividend pay date is November 21, 2024 -
What Is FibroGen’s Dividend Per Share?
FibroGen pays a dividend of $0.00 per share
FibroGen Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 103.84% |
Revenue: | 15.45% | 33.28% |
Analyst Recommendations
Buy Recommendations: | 0 |
---|---|
Hold Recommendations: | 1 |
Sell Recommendations: | 0 |
Price Target: | 0.60 |
Upside from Last Price: | 71.43% |